Thermo Fisher Scientific has today officially opened an expanded laboratory at its Cork campus, which effectively doubles its capacity to develop medicines for cancer, lupus, diabetes and psoriasis, among other illnesses.
Thermo Fisher's Cork site specialises in developing and manufacturing active pharmaceutical ingredients supporting early phase clinical studies right through to commercial supply, for a range of customers for use in life-changing treatments.
The expanded Scale-Up Laboratory is the latest aspect of expansion at the company's active pharmaceutical ingredient (API) facility since 2019.
The site has gained more than 20 global pharmaceutical and biotech customers in recent years.
Its research and development centre of excellence was officially today opened by Minister of Enterprise, Trade and Employment Simon Coveney.
"Thermo Fisher's investment in this cutting-edge laboratory underscores the innovation and collaborative spirit that drives Ireland's research and development sector. This facility will undoubtedly further position Ireland as a hub for pharmaceutical and manufacturing excellence," the Minister said.
Vincent Hingot, president of the company’s Drug Substance business, said that as a centre of excellence for chemistry development, its investment in Cork showcases Thermo Fisher's commitment to advancing development of critical medicines in Ireland.
"Our Cork colleagues are helping make life better for patients around the world," he added.
Edel Collins, general manager of the Cork site, said the 20-litre laboratory is important in the development of medicines as it allows the company to identify and address scale-up risks prior to large-scale manufacture.
"With our existing laboratory at capacity, this new one will help address current demand while creating room for growth. It will allow us to support more customers and get potentially life-saving medicines to patients faster," she added.
IDA Ireland CEO Michael Lohan said today's opening is a testament to Thermo Fisher’s commitment to fostering scientific excellence and ground breaking research in Cork.
He added that the investment bolsters Ireland's reputation as a global hub for innovation.
